MSH|^~\&|LAB|ARH|||202002120926||ORU^R01|4166280|D|2.3|||AL|NE PID|1||AB00007803|PA2506|LABTEST^ALLOSAURUS^||19851121|F||||||||||AB000896/18|9875619677 OBR|1|39278^LAB|00029632^1202:C00006R^LAB^120220:C6^39278|499.0052^QCOWCARM2^QC ONE WORLD CARDIAC MARKERS 2^^^||202002120907|202002120907|||||||202002120907||||||||||LAB|F|||| OBX|1|ST|500.5630^BNPNT R^NT-Pro-B Type Nat Peptide^^33762-6^33762-6|1|250^^Y|ng/L|<300|N||A^S|F|||202002120908 NTE|1||Heart failure is unlikely if NT-Pro BNP is <300 ng/L. NTE|2|| NTE|3||Heart failure is likely if: NTE|4|| NT-Pro BNP >450 ng/L for patients <50 years of age NTE|5|| NT-Pro BNP >900 ng/L for patients 50-75 years of age NTE|6|| NT-Pro BNP >1800 ng/L for patients >75 years of age OBX|2|ST|500.6900^CRPH^C-Reactive Protein High Sens^^30522-7^30522-7|1|5.0^^Y|mg/L|<7.5|N||A^S|F|||202002120908 NTE|1||This high sensitivity CRP method is sensitive to 0.3 mg/L NTE|2||and is suitable for coronary artery risk assessment: NTE|3|| Less than 1.0 mg/L low risk; NTE|4|| 1.0 - 3.0 mg/L intermediate risk; NTE|5|| Greater than 3.0 mg/L high risk. NTE|6||Values greater than 7.5 mg/L are significant for active NTE|7||inflammation or infection and require follow up as NTE|8||clinically needed. For consultation on specific patient NTE|9||cases call your site Medical Biochemist. Interpretation NTE|10||should be based on full history and other risk assessment NTE|11||factors.